MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today provides shareholders a ...

The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

A newly discovered molecule, OLE, restored the brain’s immune cells to a more protective state in Alzheimer’s disease models. The treatment reduced the accumulation of toxic plaques and improved ...

A team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences (IN), a joint center of the Spanish ...

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s ...

Watch a subscriber-only discussion exploring longevity's new focus. Billions of dollars are flooding into efforts to reverse ...

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one ...

The first participant has been treated in a landmark clinical trial of cellular reprogramming, which aims to rejuvenate aging ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

Modern clinical and corporate environments frequently suffer from "the extinction of experience"—they are sterile, structurally impoverished, and cognitively draining. 🧪 Happier Neurotransmitters: ...